Breaking News Instant updates and real-time market news.

SDC

SmileDirectClub

$11.72

1.51 (14.79%)

, ARLP

Alliance Resource Partners

$11.22

-0.21 (-1.84%)

08:45
01/15/20
01/15
08:45
01/15/20
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: SmileDirectClub (SDC) 18.50% +0.62, Alliance Resource Partners (ARLP) 13.97% +0.14, AMC Entertainment (AMC) 56.20% +0.12, Fortuna Silver Mines (FSM) 0.59% +0.09, Direxion Daily Gold Miners Bull 3X Shares (NUGT) 1.24% +0.08, Cronos Group (CRON) 10.71% +0.08, ProShares Ultra S&P 500 (SSO) 1.39% +0.06, Plains All American (PAA) 0.50% +0.05, Discovery (DISCA) 0.31% +0.05, and Fossil Group (FOSL) 0.43% +0.05.

SDC

SmileDirectClub

$11.72

1.51 (14.79%)

ARLP

Alliance Resource Partners

$11.22

-0.21 (-1.84%)

AMC

AMC Entertainment

$6.86

0.29 (4.41%)

FSM

Fortuna Silver Mines

$3.76

0.075 (2.04%)

NUGT

Direxion Gold Miners Bull

$30.88

1.53 (5.21%)

CRON

Cronos Group

$7.89

0.38 (5.06%)

SSO

ProShares Ultra S&P 500

$155.96

-0.4 (-0.26%)

PAA

Plains All American

$18.61

0.03 (0.16%)

DISCA

Discovery

$31.89

0.115 (0.36%)

FOSL

Fossil

$7.93

0.69 (9.53%)

  • 27

    Jan

  • 04

    Feb

  • 27

    Feb

SDC SmileDirectClub
$11.72

1.51 (14.79%)

01/15/20
JEFF
01/15/20
NO CHANGE
JEFF
SmileDirect traditional channel entry makes competitive 'noise,' says Jefferies
Jefferies analyst Brandon Couillard said SmileDirectClub's (SDC) plans to enter the U.S. in-office, doctor-directed channel for aligners opens a new potential source of unit growth for the company and might soften scrutiny from the "dental establishment". Meanwhile, the move creates more competition "noise" for Align Technology (ALGN), Envista (NVST) and Dentsply Sirona (XRAY) and could be a source of near-term volatility for those stocks, although he said there is "still a lot to be fleshed out." While he thinks the negative read-throughs "are obvious," he said some potential positives include the fact that SmileDirect confirmed that the in-office market is still very relevant and that he sees clear differentiation between the aligners offered by Align and Envista when compared to SmileDirect.
01/14/20
STFL
01/14/20
NO CHANGE
Target $17
STFL
Buy
SmileDirectClub wholesale entrance offers 'incremental' sales, says Stifel
SmileDirectClub (SDC) this morning said it will start offering its clear aligners through the wholesale channel and sell to dentists and orthodontists rather than just directly to the consumer, Stifel analyst Jonathan Block tells investors in a research note. The company's wholesale initiative, if successful, would offer "largely incremental" revenue to its current direct-to-consumer model, contends the analyst. He keeps a Buy rating on SmileDirectClub with a $17 price target.
01/09/20
WOLF
01/09/20
INITIATION
Target $7
WOLF
Underperform
SmileDirectClub initiated with an Underperform at Wolfe Research
Wolfe Research initiated coverage of SmileDirectClub with an Underperform rating and $7 price target. While the firm believes multiple compression in 2019 has set up the stock up for outperformance on any positive surprise, its rating seeks to highlight the likelihood of deceleration, future capital raises, and the stock's macro and credit sensitivity.
01/06/20
CHLM
01/06/20
INITIATION
Target $20
CHLM
Buy
SmileDirectClub initiated with a Buy at Craig-Hallum
Craig-Hallum analyst Alexander Nowak initiated coverage of SmileDirectClub with a Buy rating and $20 price target. The company is is "upsetting the existing mold" of orthodontics by lowering physician involvement to provide increased access, better service and a reduced cost to the consumer, Nowak tells investors in a research note. The analyst believes SmileDirectClub is setting itself up for "many years of share gains while insulating itself from potential copy-cats." With 3% share today and a growing market, the company's business is "just getting going" and the current valuation is a good entry point for investors, contends Nowak. He expects its revenue to more than double in the next two years.
ARLP Alliance Resource Partners
$11.22

-0.21 (-1.84%)

08/19/19
08/19/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Air Products (APD) downgraded to Neutral from Positive at Susquehanna. 2. Whiting Petroleum (WLL) downgraded to Sector Perform from Outperform at Scotiabank and to Equal Weight from Overweight at Stephens. 3. Celgene (CELG) and Amgen (AMGN) downgraded to Neutral from Buy at Mizuho. 4. Alliance Resource Partners (ARLP) and Peabody Energy (BTU) downgraded to Neutral from Overweight at JPMorgan. 5. Trillium Therapeutics (TRIL) downgraded to Neutral from Buy at H.C. Wainwright with analyst Swayampakula Ramakanth saying the stock's 80% drop in price to 26c per share from $1.32 in the last six months could "lead to a cash crunch," leaving significant risk for its ability to raise sufficient capital to fund ongoing clinical studies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/19/19
JPMS
08/19/19
DOWNGRADE
Target $22
JPMS
Neutral
Alliance Resource Partners downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst John Bridges downgraded Alliance Resource Partners (ARLP) to Neutral from Overweight, saying coal stock prices have fallen well below his and the Street's price targets based on long-term value, and cites the rising risk of recession for the downgrade as he feels better entry points could develop. The analyst, who also downgraded Peabody Energy (BTU), lowered his price target to $22 from $23 to highlight the potential of the coal stocks to deliver a tobacco-like recovery on the basis that while the sector's products are unpopular they are still needed.
08/19/19
JPMS
08/19/19
DOWNGRADE
Target $30
JPMS
Neutral
Peabody Energy downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst John Bridges downgraded Peabody Energy (BTU) to Neutral from Overweight, saying coal stock prices have fallen well below his and the Street's price targets based on long-term value, and cites the rising risk of recession for the downgrade as he feels better entry points could develop. The analyst, who also downgraded Alliance Resource Partners (ARLP), lowered his price target to $30 from $35 to highlight the potential of the coal stocks to deliver a tobacco-like recovery on the basis that while the sector's products are unpopular they are still needed.
07/29/19
GHSC
07/29/19
DOWNGRADE
GHSC
Neutral
Seaport Global downgrades Alliance Resource Partners to Neutral on weak view
As previously reported, Seaport Global analyst Mark Levin downgraded Alliance Resource Partners to Neutral from Buy after the company reported quarterly results that were much weaker than expected and management cut its full-year shipment and exports guidance. Given depressed export market conditions and low natural gas prices, he thinks there is at least some possibility the company's distribution coverage falls below 1.0x in calendar 2020, Levin tells investors.
AMC AMC Entertainment
$6.86

0.29 (4.41%)

12/18/19
BOFA
12/18/19
DOWNGRADE
Target $7
BOFA
Underperform
BofA/Merrill downgrades AMC Entertainment to Underperform with $7 target
BofA/Merrill analyst Bryan Goldberg downgraded AMC Entertainment (AMC) to Underperform from Neutral with a price target of $7, down from $14. The analyst sees a "tough" compares for the 2020 film slate and highlights the lapping of Stubs A-List price increase. Further, he sees a continued rise in perceived competition from small screen competitors such as Netflix (NFLX) as well as high leverage at AMC.
12/18/19
BOFA
12/18/19
DOWNGRADE
BOFA
Underperform
AMC Entertainment downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Bryan Goldberg downgraded AMC Entertainment to Underperform from Neutral.
11/22/19
RILY
11/22/19
NO CHANGE
RILY
B. Riley FBR downgrades Cinemark and Marcus, cuts exhibitor targets
B. Riley FBR analyst Eric Wold revisited his exhibitor coverage heading into the "most important stretch" of the Q4 film slate, which will bring Frozen II, Jumanji: The Next Level, and Star Wars: The Rise of Skywalker to screens. However, with the quarter-to-date box office down 14.7%, the analyst now believes Q4 could be relatively flattish year-over-year versus consensus expectations for a mid-single-digit increase. As a result, he lowered his Q4 estimates for the group and believes the full-year 2019 box office could decline around 4.0%. Wold downgraded both Cinemark (CNK) and Marcus (MCS) to Neutral from Buy, saying short-term domestic box office movements are more likely to influence valuation decisions over the next 12-18 months. The analyst also lowered his price target for Buy-rated AMC Entertainment (AMC) to $15 from $19, for Buy-rated Imax (IMAX) to $30 from $34, and for Neutral-rated National CineMedia (NCMI) to $7.50 from $8.50.
12/18/19
12/18/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. FedEx (FDX) downgraded to Perform from Outperform at Oppenheimer with analyst Scott Schneeberger saying the company's Q2 results were weaker than expected on a lighter than expected Express/Ground segment performance. 2. Domino's Pizza (DPZ) downgraded to Neutral from Buy at Longbow with analyst Alton Stump citing valuation. 3. AMC Entertainment (AMC) downgraded to Underperform from Neutral at BofA/Merrill with analyst Bryan Goldberg saying he sees a "tough" compares for the 2020 film slate and highlights the lapping of Stubs A-List price increase. 4. Halliburton (HAL) downgraded to Market Perform from Outperform at BMO Capital with analyst Daniel Boyd saying while down 7% year-to-date, Halliburton is the best performing large cap energy stock over the past three months on positive changes in frac fundamentals, macro improvements, and high short interest. 5. Galapagos (GLPG) downgraded to Neutral from Buy at Citi with analyst Nick Nieland saying he views the current valuation as fair and sees fewer clinical catalysts into the first half of 2020. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
FSM Fortuna Silver Mines
$3.76

0.075 (2.04%)

09/13/19
ADAM
09/13/19
UPGRADE
ADAM
Buy
Fortuna Silver Mines upgraded to Buy from Hold at Canaccord
Canaccord analyst Dalton Baretto upgraded Fortuna Silver Mines to Buy from Hold but lowered his price target on the stock to C$5.50 from C$6.00. Fortuna announced the start of pre-production mining at its 100% owned Lindero gold Project and while the company continues to guide to 145-160koz of production in the mine's first 12 months of operation, Baretto conservatively assumes a slower ramp-up, he said. He cites the stock's recent weakness for his change in rating.
09/10/19
SCOT
09/10/19
UPGRADE
Target $5
SCOT
Outperform
Fortuna Silver Mines upgraded to Outperform from Sector Perform at Scotiabank
Scotiabank analyst Trevor Turnbull upgraded Fortuna Silver Mines to Outperform from Sector Perform with a $5 price target saying the company is nearing completion of its Lindero heap leach gold mine in Argentina and projects 16% free cash flow yield next year.
08/08/19
ADAM
08/08/19
DOWNGRADE
ADAM
Hold
Fortuna Silver Mines downgraded to Hold from Buy at Canaccord
Canaccord analyst Dalton Baretto downgraded Fortuna Silver Mines to Hold from Buy with an unchanged price target of C$6.00.
03/14/19
03/14/19
UPGRADE

Buy
Fortuna Silver Mines upgraded to Buy on valuation at Canaccord
As previously reported, Canaccord analyst Dalton Baretto upgraded Fortuna Silver Mines to Buy from Hold, with a C$5.50 price target, after the company reported Q4 results. The analyst cited the 16% implied return to his price target.
NUGT Direxion Gold Miners Bull
$30.88

1.53 (5.21%)

CRON Cronos Group
$7.89

0.38 (5.06%)

10/16/19
BOFA
10/16/19
NO CHANGE
BOFA
BofA lowers cannabis stock price targets on further sales estimate changes
Following yesterday's rally in cannabis stock's driven by Aphria's (APHA) earnings, BofA Merrill Lynch analyst Christopher Carey said he doesn't see a case for sustainable upside yet until consensus estimates are cut further, which he thinks will ensue with the calendar Q3 results from the group. The reason that industry sales could be flat to down quarter-over-quarter sector-wide is that the cannabis industry is going from a period of inventory build to one of inventory "de-load," said Carey. Given his sales estimate revisions, he has lowered his price target on Aurora Cannabis (ACB) shares to $5 from $6, cut his Canopy Growth (CGC) price target to $23 from $27, trimmed his Cronos Group (CRON) target to $13 from $16 and decreased his Hexo (HEXO) target to $2 from $2.50. Carey keeps a Buy rating on Cronos, has Neutral ratings on Aurora and Canopy and maintains an Underperform rating on Hexo.
10/18/19
STFL
10/18/19
UPGRADE
STFL
Buy
Cronos Group upgraded to Buy from Hold at Stifel
Stifel analyst Andrew Carter upgraded Cronos Group (CRON) to Buy from Hold with a price target of C$14.00, down from C$16.50. The analyst Cronos is "unconstrained" in its ability to invest towards a $200B global opportunity with C$2B in cash on hand the resources of Altria Group (MO), Carter tells investors in a research note titled "Crowning a New King in the North." The analyst believes Cronos will show an "enhanced revenue growth profile" that leverages the distribution capabilities of Altria to build its U.S. CBD business and demonstrate "break-through product potential" in the Canadian vapor segment. Given the company's "advantaged and enhanced position," investors should buy Cronos shares following their recent pullback, says Carter.
11/05/19
BOFA
11/05/19
NO CHANGE
BOFA
BofA says Mexico cannabis legalization 'still in play' in 2020 after extension
BofA Merrill Lynch analyst Christopher Carey noted that Mexico's Supreme Court has granted an extension until April 30, 2020 for Congress to legalize all forms of cannabis, writing in its decision that considering the complexity of the issue it grants the extension "exceptionally and for one time only." He views this as an important development for the industry since, in addition to opening a potentially large market, it will put even more pressure on U.S. federal action as the country will potentially "place the US between 2 of only 3 countries in the world to have legalized cannabis for recreational use." 9% of Mexico's population of 131M is estimated to have consumed cannabis in 2018 and the legal market could be worth $1B by 2024, according to BDS Analytics, noted Carey. Publicly traded companies in the cannabis space include Aphria (APHA), Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC), Tilray (TLRY) and Trulieve Cannabis (TCNNF).
10/22/19
PIPR
10/22/19
NO CHANGE
Target $12
PIPR
Overweight
Piper cuts targets in Cannabis, says Canopy and Cronos best positioned
Piper Jaffray analyst Michael Lavery revisited the four Canadian licensed producers under his coverage, namely Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON) and Tilray (TLRY). The analyst continues to believe Canopy and Cronos look best positioned. Both companies have strong cash positions to facilitate growth and have good visibility on key strategic priorities, Lavery tells investors in a research note. The analyst cut his estimates for Tilray, but he keeps an Overweight rating on the shares as he still sees growth potential in both Europe and the U.S. Lavery believes Aurora lacks visibility on key strategic growth priorities and he keeps a Neutral rating on the shares. The analyst lowered his price target for Aurora to $4 from $7, for Canopy to $36 from $40, for Cronos to $12 from $18, and for Tilray to $31 from $72.
SSO ProShares Ultra S&P 500
$155.96

-0.4 (-0.26%)

PAA Plains All American
$18.61

0.03 (0.16%)

12/18/19
JEFF
12/18/19
NO CHANGE
JEFF
Equitrans Midstream added to Franchise Picks list at Jefferies
Jefferies analyst Christopher Sighinolfi said U.S. midstream equity performance in 2019 has been overshadowed by commodity price weakness and "growing trepidation," but he sees compelling midstream value amid declining leverage, moderating capital spending, escalating free cash flow and third-party M&A. He remains most constructive on the Midstream sector within the broader Midstream & Refining space and favors Williams (WMB) and Equitrans Midstream (ETRN) among the C-corps, adding the latter to the firm's Franchise Picks list. In the MLP group, he prefers Enterprise Products (EPD), Energy Transfer (ET) and Plains All American (PAA), Sighinolfi added.
01/06/20
MSCO
01/06/20
INITIATION
Target $19
MSCO
Equal Weight
Plains All American initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Stephen Byrd initiated coverage of Plains All American with an Equal Weight rating and $19 price target as part of his broader initiation of coverage of MLPs & Midstream Energy Infrastructure with an In-Line industry view.
01/14/20
LEHM
01/14/20
NO CHANGE
LEHM
Barclays changes ratings in MLPs, Diversified Natural Gas space
Barclays analysts including Christine Cho upgraded Plains All American (PAA), Plains GP Holdings (PAGP), Magellan Midstream (MMP), Crestwood Equity (CEQP) and TC PipeLines (TCP) to Overweight from Equal Weight while downgrading Kinder Morgan (KMI), Williams (WMB), Noble Midstream (NBLX), MPLX (MPLX), and CNX Midstream Partners (CNXM) to Equal Weight from Overweight. The downgrades of Williams and MPLX reflect their Northeast gas exposure. While expectations are reset given their respective underperformances in the back half of last year, outperformance in 2020 is unlikely, Cho tells investors in a research note. The changes in Plains, Kinder Morgan and and CNX are valuation calls. The analyst says the Magellan Midstream and TCP upgrades are "quality names" with the former likely announcing some form of capital return to shareholders while the latter continues to build up an organic backlog of solid returning projects. For Crestwood, Cho believes its concentration in the Bakken and a resumption for distribution growth will support the stock while a lack of catalysts and a more subdued growth outlook prompts a move to the sidelines.
01/14/20
LEHM
01/14/20
UPGRADE
Target $24
LEHM
Overweight
Plains All American upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Christine Cho upgraded Plains All American Pipeline to Overweight from Equal Weight with a $24 price target.
DISCA Discovery
$31.89

0.115 (0.36%)

11/04/19
RSBL
11/04/19
INITIATION
Target $30
RSBL
Neutral
Discovery initiated with a Neutral at Rosenblatt
Rosenblatt analyst Brian McTernan initiated coverage of Discovery with a Neutral rating and $30 price target.
10/22/19
10/22/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Discovery (DISCA) upgraded to Outperform from In-Line at Imperial Capital with analyst David Miller sayign amidst changes in the Media sector, and against "various levels of turmoil" within many of the company's peers, Discovery has emerged "as one of the cleaner stories in the sector." 2. Dropbox (DBX) upgraded to Buy from Neutral at Nomura Instinet with analyst Christopher Eberle saying the company is nearing an inflection in revenue after six quarters of deceleration as a public company and its current valuation is attractive. 3. Workday (WDAY) and Anaplan (PLAN) upgraded to Outperform from In Line at Evercore ISI. 4. Owens Corning (OC) upgraded to Buy from Neutral at Buckingham with analyst Megan McGrath saying the company's installation business should benefit from recent improved volumes in residential U.S. construction and potentially improved price stability. 5. Bank of America (BAC) upgraded to Overweight from Neutral at Atlantic Equities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/11/19
RSBL
11/11/19
NO CHANGE
Target $33
RSBL
Neutral
Discovery price target raised to $33 from $30 at Rosenblatt
Rosenblatt analyst Brian McTernan raised his price target on Discovery shares to $33 from $30 following the company's "strong" Q3 report, which he believes "checked an important box." He raised his 2020 free cash flow per share estimate by about 8% following the report, driven by higher international distribution revenue and higher buybacks, but he keeps a Neutral rating on the shares as McTernan anticipates Discovery's subscriber declines "will begin to look like the rest of the industry" in 2020 as it will no longer be benefiting from incremental carriage from virtual multichannel video programming distributor, or MVPDs.
10/22/19
IMPC
10/22/19
UPGRADE
Target $34
IMPC
Outperform
Discovery upgraded to Outperform from In-Line at Imperial Capital
Imperial Capital analyst David Miller upgraded Discovery to Outperform from In-Line with a price target of $34, up from $29. Amidst changes in the Media sector, and against "various levels of turmoil" within many of the company's peers, Discovery has emerged "as one of the cleaner stories in the sector," Miller tells investors in a research note. Investors seems to have forgotten that, beginning September 24, 2020, Discovery will have pan-European rights to the summer Olympic games in Tokyo, adds the analyst. He sees multiple catalysts for the shares and recommends buying the stock ahead of the company's Q3 earnings call on November 7.
FOSL Fossil
$7.93

0.69 (9.53%)

11/07/19
KEYB
11/07/19
DOWNGRADE
KEYB
Sector Weight
Fossil turnaround 'has not manifested,' says KeyBanc
KeyBanc analyst Edward Yruma downgraded Fossil to Sector Weight from Overweight. In a research note to investors, Yruma says that the turnaround driven by wearable growth and traditional watch stabilization has not manifested. While Fossil has made progress with its wearable strategy, Yruma says competitors continue to drive the bulk of growth in the wearable category.
11/07/19
KEYB
11/07/19
DOWNGRADE
KEYB
Sector Weight
Fossil downgraded to Sector Weight from Overweight at KeyBanc
KeyBanc analyst Edward Yruma downgraded Fossil to Sector Weight from Overweight.
02/14/19
WELS
02/14/19
NO CHANGE
Target $8
WELS
Underperform
Fossil price target lowered to $8 from $14 at Wells Fargo
Wells Fargo analyst Ike Boruchow lowered his price target for Fossil to $8 from $14 following quarterly results and as the analyst expects the top-line to remain under pressure with very little visibility into a turn in trend. Given that the secular pressure on traditional watches is far from abating, the falloff in wearables truly hurts any real bull case that was able to be made prior, he contends. Boruchow reiterates an Underperform rating on the shares.

TODAY'S FREE FLY STORIES

SPOT

Spotify

$148.20

-3.59 (-2.37%)

18:15
01/17/20
01/17
18:15
01/17/20
18:15
Periodicals
Spotify in talks to acquire The Ringer, WSJ reports »

Spotify is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

CE

Celanese

$117.54

-0.53 (-0.45%)

18:00
01/17/20
01/17
18:00
01/17/20
18:00
Hot Stocks
Celanese announces acetyl intermediates price increases »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

BYND

Beyond Meat

$109.20

-1.16 (-1.05%)

17:58
01/17/20
01/17
17:58
01/17/20
17:58
Periodicals
Beyond Meat rival gets green light in Canada, The Star says »

Impossible Foods, a maker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBD

Diebold

$11.09

-0.49 (-4.23%)

17:42
01/17/20
01/17
17:42
01/17/20
17:42
Periodicals
Breaking Periodicals news story on Diebold »

Diebold Nixdorf divests…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEF

iShares 7-10 Year Treasury Bond ETF

$111.28

-0.13 (-0.12%)

, SHY

iShares 1-3 Year Treasury Bond

$84.73

-0.005 (-0.01%)

17:32
01/17/20
01/17
17:32
01/17/20
17:32
General news
Weekly CFTC Commitment of Traders highlights »

2-YEAR U.S. TREASURY net…

IEF

iShares 7-10 Year Treasury Bond ETF

$111.28

-0.13 (-0.12%)

SHY

iShares 1-3 Year Treasury Bond

$84.73

-0.005 (-0.01%)

SPY

SPDR S&P 500 ETF Trust

$331.98

1.08 (0.33%)

SLV

iShares Silver Trust

$16.82

0.04 (0.24%)

GLD

SPDR Gold Shares

$146.59

0.29 (0.20%)

FXE

Euro Currency Trust

$105.10

-0.43 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBSFY

Ubisoft

$0.00

(0.00%)

17:32
01/17/20
01/17
17:32
01/17/20
17:32
Periodicals
Ubisoft to restructure editorial team after difficult 2019, VGC reports »

Ubisoft intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Feb

IMVT

Immunovant

$17.04

-0.01 (-0.06%)

17:27
01/17/20
01/17
17:27
01/17/20
17:27
Syndicate
Breaking Syndicate news story on Immunovant »

Immunovant files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBLT

ToughBuilt

$0.33

-0.0255 (-7.11%)

17:20
01/17/20
01/17
17:20
01/17/20
17:20
Syndicate
ToughBuilt files to sell common stock, no amount given »

Maxim acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYO

Myomo

$0.32

0.0062 (1.98%)

17:18
01/17/20
01/17
17:18
01/17/20
17:18
Conference/Events
Myomo to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

SRRA

Sierra Oncology

$0.40

-0.02 (-4.76%)

17:14
01/17/20
01/17
17:14
01/17/20
17:14
Conference/Events
Sierra Oncology to host virtual special shareholder meeting »

Virtual Special…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

SRNE

Sorrento Therapeutics

$4.26

-0.15 (-3.40%)

17:10
01/17/20
01/17
17:10
01/17/20
17:10
Syndicate
Breaking Syndicate news story on Sorrento Therapeutics »

Sorrento Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKER

Akers Biosciences

$3.45

-0.1 (-2.82%)

17:01
01/17/20
01/17
17:01
01/17/20
17:01
Hot Stocks
Akers Biosciences reaches settlement agreements on two derivative actions »

Akers Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECA

Encana

$4.09

-0.18 (-4.22%)

16:40
01/17/20
01/17
16:40
01/17/20
16:40
Hot Stocks
Encana receives court approval for reorganization »

Encana Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

MBRX

Moleculin Biotech

$0.96

0.0122 (1.29%)

16:38
01/17/20
01/17
16:38
01/17/20
16:38
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOD

Vodafone

$20.07

-0.225 (-1.11%)

, BT

BT Group

$0.00

(0.00%)

16:37
01/17/20
01/17
16:37
01/17/20
16:37
Periodicals
BT, Vodafone consider urging PM Johnson not to ban Huawei in U.K., Reuters says »

BT Group (BT) and…

VOD

Vodafone

$20.07

-0.225 (-1.11%)

BT

BT Group

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
01/17/20
01/17
16:30
01/17/20
16:30
Options
Preliminary option volume of 28.7M today »

Preliminary option volume…

NSCO

Nesco Holdings

$5.12

0.025 (0.49%)

16:26
01/17/20
01/17
16:26
01/17/20
16:26
Syndicate
Nesco Holdings requests withdrawal of registration statement »

Nesco Holdings has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$18.54

-0.075 (-0.40%)

, CMCSA

Comcast

$47.48

0.62 (1.32%)

16:20
01/17/20
01/17
16:20
01/17/20
16:20
On The Fly
Fly Intel: Wall Street's top stories for Friday »

The major averages were…

GPS

Gap

$18.54

-0.075 (-0.40%)

CMCSA

Comcast

$47.48

0.62 (1.32%)

CMCSK

Comcast

$0.00

(0.00%)

PLAY

Dave & Buster's

$47.35

5.3 (12.60%)

KKR

KKR

$31.20

0.7 (2.30%)

BA

Boeing

$324.11

-7.89 (-2.38%)

JNJ

Johnson & Johnson

$149.07

0.82 (0.55%)

SWK

Stanley Black & Decker

$172.63

2.18 (1.28%)

TWOU

2U

$22.84

1.05 (4.82%)

BE

Bloom Energy

$9.70

0.43 (4.64%)

MGPI

MGP Ingredients

$38.16

-14.74 (-27.86%)

FAST

Fastenal

$36.77

-0.55 (-1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 20

    Jan

  • 22

    Jan

  • 23

    Jan

  • 29

    Jan

  • 29

    Jan

  • 31

    Jan

  • 26

    Feb

  • 27

    Feb

  • 09

    Mar

  • 17

    Mar

APLS

Apellis

$40.43

0.03 (0.07%)

16:18
01/17/20
01/17
16:18
01/17/20
16:18
Hot Stocks
Apellis CEO sells 30.6K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
01/17/20
01/17
16:17
01/17/20
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
01/17/20
01/17
16:16
01/17/20
16:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:15
01/17/20
01/17
16:15
01/17/20
16:15
General news
Treasury Market Summary »

Treasury Market Summary:…

LGC

Legacy Acquisition Corp

$10.33

(0.00%)

16:08
01/17/20
01/17
16:08
01/17/20
16:08
Hot Stocks
Legacy Acquisition Corp extends date to consummate proposed business combination »

Legacy Acquisition Corp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNUS

Genius Brands

$0.33

-0.015 (-4.41%)

16:04
01/17/20
01/17
16:04
01/17/20
16:04
Syndicate
Breaking Syndicate news story on Genius Brands »

Genius Brands files $50M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$90.21

1.28 (1.44%)

16:04
01/17/20
01/17
16:04
01/17/20
16:04
Periodicals
Best Buy board opens investigation into CEO's personal conduct, WSJ says »

The board of Best Buy is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.